Management of early pregnancy loss with mifepristone and misoprostol: clinical predictors of success from a randomized trial

BACKGROUND: Early pregnancy loss (EPL) is a common event in the first trimester, occurring in 15–20% of recognized pregnancies. A common evidence-based medical regimen for EPL management uses the prostaglandin E1 analogue misoprostol 800 mcg self-administered vaginally. The clinical utility of this...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Obstet Gynecol
Main Authors: SONALKAR, Sarita, KOELPER, Nathanael, CREININ, Mitchell D., ATRIO, Jessica M., SAMMEL, Mary D., McALLISTER, Arden, SCHREIBER, Courtney A.
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7529708/
https://ncbi.nlm.nih.gov/pubmed/32305259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2020.04.006
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki